Skip To The Main Content

FDA Issues Guidance on New Steps to Promote Generic Drugs

The United States Food and Drug Administration (FDA) has issued guidance on new steps it is taking to promote generic drugs so as to make more affordable therapies available to the public.  The FDA aims to reduce tactics by companies to frustrate generic drug use, improve the timing and efficiency of its own regulatory approval process, and resolve scientific obstacles to generically formulating complex drugs.  To read the FDA announcement and summary of the new steps it is taking to promote generic drugs, use the link below.